Regeneron Pharmaceuticals, Inc. (REGN): Shareholders' Equity
$31.26B
As of 2025-12-31
$31.71B
As of 2026-06-30
+11.3%
3-year compound annual growth
+23.2%
5-year compound annual growth
+23.9%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $31.26B | +6.5% | 2026-02-04, Balance as of period end |
| 2024-12-31 | $29.35B | +13.0% | 2026-02-04, Balance as of period end |
| 2023-12-31 | $25.97B | +14.6% | 2026-02-04, Balance as of period end |
| 2022-12-31 | $22.66B | +20.8% | 2025-02-05, Balance as of period end |
| 2021-12-31 | $18.77B | +70.2% | 2024-02-05, Balance as of period end |
| 2020-12-31 | $11.03B | -0.6% | 2023-02-06, Balance as of period end |
| 2019-12-31 | $11.09B | +26.6% | 2022-02-07, Balance as of period end |
| 2018-12-31 | $8.76B | +42.5% | 2021-02-08, Balance as of period end |
| 2017-12-31 | $6.14B | +38.1% | 2020-02-07, Balance as of period end |
| 2016-12-31 | $4.45B | +21.7% | 2019-02-07, Balance as of period end |
| 2015-12-31 | $3.65B | +43.3% | 2018-02-08, Balance as of period end |
| 2014-12-31 | $2.55B | +29.8% | 2017-02-09, Balance as of period end |
| 2013-12-31 | $1.96B | +57.8% | 2016-02-11, Balance as of period end |
| 2012-12-31 | $1.25B | +156.4% | 2015-02-12, Balance as of period end |
| 2011-12-31 | $485.73M | -8.0% | 2014-02-13, Balance as of period end |
| 2010-12-31 | $527.82M | +33.0% | 2013-02-15, Balance as of period end |
| 2009-12-31 | $396.76M | -5.9% | 2012-02-21, Balance as of period end |
| 2008-12-31 | $421.51M | n/a | 2011-02-17, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $31.26B | +6.5% |
| Viatris Inc (VTRS) | 2025-12-31 | $14.71B | -21.1% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $18.67B | +13.7% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $7.91B | +47.1% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $377.00M | n/m |
| Zoetis Inc. (ZTS) | 2025-12-31 | $3.33B | -30.2% |
| Organon & Co. (OGN) | 2025-12-31 | $752.00M | +59.3% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.36B | +30.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.55B | +7.4% |
Compare REGN, VTRS, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗